The estimated prevalence of cigarette smoking in the HIV-seropositive population is ~ 50%, over double that in the general population. Furthermore, persons infected with HIV appear to be especially susceptible to the adverse effects of cigarette smoking. Of particular relevance to this RFA is convincing evidence that prior to the onset of AIDS-related pulmonary complications, HIV-seropositive individuals are at increased risk of developing accelerated emphysema. This risk appears to be related to an increased susceptibility to cigarette smoke. In light of the aging of the HIV-seropositive population, the high prevalence of cigarette smoking in this group, and it's increased risk of smoking related lung damage, it is possible that chronic obstructive pulmonary disease (COPD) will soon dwarf other HIV-related pulmonary complications in terms of disease burden. With this as a background, the overall objective of the current proposal is to not merely examine the natural history of HIV-related emphysema in the HAART era, but to investigate whether that natural history can be altered. Indeed, while numerous investigators have highlighted the importance of smoking cessation in HIV-seropositive individuals, there is strikingly little research into this area. The current proposal will study the effect of smoking cessation on the course of HIV-associated emphysema from the symptomatic, physiologic and biologic perspective. As such, we will pursue the following specific aims:
Specific Aim 1 : To develop and evaluate a specialized smoking cessation intervention for the treatment of nicotine dependence in HIV-seropositive smokers.
Specific Aim 2 : To examine the effects of smoking cessation on the course of lung function decline, the prevalence of respiratory symptoms and the occurrence/progression of emphysema in a cohort of HIV- seropositive individuals.
Specific Aim 3 : To explore the effects of smoking cessation on the biology of alveolar macrophages obtained from HIV-seropositive individuals. This proposal is highly significant. To begin with, it will shed insight into the natural history of emphysema in a very susceptible population, advancing our understanding of HIV-related pulmonary complications and the emphysema process in general. More importantly, the proposal will begin to address the efficacy of a smoking cessation regimen in a patient population with an extremely high smoking prevalence. As such, the results obtained herein will have important and immediate clinical relevance.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-Z (S1))
Program Officer
Peavy, Hannah H
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Segal, Leopoldo N; Clemente, Jose C; Li, Yonghua et al. (2017) Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients. Cell Host Microbe 21:530-537.e4
Leader, Joseph K; Crothers, Kristina; Huang, Laurence et al. (2016) Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort. J Acquir Immune Defic Syndr 71:420-7
Browning, Kristine K; Wewers, Mary Ellen; Ferketich, Amy K et al. (2016) Adherence to Tobacco Dependence Treatment Among HIV-Infected Smokers. AIDS Behav 20:608-21
Drummond, M Bradley; Huang, Laurence; Diaz, Philip T et al. (2015) Factors associated with abnormal spirometry among HIV-infected individuals. AIDS 29:1691-700
Browning, Kristine K; Wewers, Mary Ellen; Ferketich, Amy K et al. (2013) Tobacco use and cessation in HIV-infected individuals. Clin Chest Med 34:181-90
Ferketich, Amy K; Diaz, Philip; Browning, Kristine K et al. (2013) Safety of varenicline among smokers enrolled in the lung HIV study. Nicotine Tob Res 15:247-54
Crothers, Kristina; McGinnis, Kathleen; Kleerup, Eric et al. (2013) HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr 64:271-8
Crothers, Kristina; Thompson, Bruce W; Burkhardt, Kathryn et al. (2011) HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc 8:275-81
Rahmanian, Shiva; Wewers, Mary Ellen; Koletar, Susan et al. (2011) Cigarette smoking in the HIV-infected population. Proc Am Thorac Soc 8:313-9
Reynolds, Nancy R (2009) Cigarette smoking and HIV: more evidence for action. AIDS Educ Prev 21:106-21